1 / 14

PHARMACOECONOMICS and RATIONAL DRUG USE DRAFT PROGRAM FOR 1 st ISPOR INTERNATIONAL SUMMER SCHOOL ISPOR SCP (TURKEY) AN

PHARMACOECONOMICS and RATIONAL DRUG USE DRAFT PROGRAM FOR 1 st ISPOR INTERNATIONAL SUMMER SCHOOL ISPOR SCP (TURKEY) ANTALYA, APRIL 17-21, 2008.

avani
Télécharger la présentation

PHARMACOECONOMICS and RATIONAL DRUG USE DRAFT PROGRAM FOR 1 st ISPOR INTERNATIONAL SUMMER SCHOOL ISPOR SCP (TURKEY) AN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PHARMACOECONOMICS and RATIONAL DRUG USEDRAFT PROGRAM FOR 1st ISPOR INTERNATIONAL SUMMER SCHOOL ISPOR SCP (TURKEY)ANTALYA, APRIL 17-21, 2008

  2. Antalya was founded in the second century BC by a king of Pergamon (Bergama), Attalus II. He needed a harbour in the South and had to found a new city since all the other harbours were under (bought) Roman protection. The city fast outgrew the nearby Side in importance. In 67 Pompeius used it as a basis for his fight against pirates. In 130 emperor Hadrian visited the city, and for the occasion a great arch was erected. Hadrian improved the cities defences and made it the capital of a new province. In 1207 the Seljuks conquered the city, and used it as a winter residence. Murat II integrated it into the Ottoman empire in the late 14th century.

  3. April 17 Thursday • Check in • 18.00 Welcome; 20.00 Dinner • April 18 Friday • 08.30 – 09.20: ISPOR SCP and Why do we need pharmacoeconomics and rational drug use? • 09.20 – 10.10: General economics and health expenditures – TR • 10.10 – 10.30: Coffee Break • 10.30 – 11.20: Principles of pharmacoeconomics • Academics • 11.20 – 12.10: Pharmacoeconomics for decision makers • Academics • 12.10 – 13.30: Lunch • 13.30 – 14.20: GSS and SGK in Turkey; next 2 years • Government speaker • 14.20 – 15.10: Principles of Rational drug use • 15.10 – 15.30: Coffee Break • 15.30 – 16.20: DRGs and payment systems • 16.20 – 17.10: How to apply rational drug use in the new system: The role of generic drugs

  4. April 19 Saturday • 08.30 – 09.20: Reference pricing and competition?/budget impact • 09.20 – 10.10: Reimbursement systems across Europe • 10.10 – 10.30: Coffee Break • 10.30 – 11.20: Quality of life and patient reported outcomes • 11.20 – 12.10: What are we paying for? • 12.10 – 13.30: Lunch • 13.30 – 14.20: Budget impact of new technologies • 14.20 – 15.10: Why do we need real life data with local costs? • 15.10 – 15.30: Coffee Break • 15.30 – 16.20: Pharmacoeconomics alongside clinical trials • 16.20 – 17.10: Modeling methods and why do we need modeling?

  5. April 20 Sunday • 08.30 – 09.20: How does Social Security Agencies make a decision? • 09.20 – 10.10: How to prepare a reimbursement file? • 10.10 – 10.30: Coffee Break • 10.30 – 11.20: What does it mean for the pharma sector 1? National Drug Manufacturers • 11.20 – 12.10: What does it mean for the pharma sector 2? Multinational Drug Companies • 12.10 – 13.30: Lunch • 13.30 – 14.20: Workshop; Reimbursement File Preparation 1 • 14.20 – 15.10: Workshop; Reimbursement File Preparation 2 • 15.10 – 15.30: Coffee Break • 15.30 – 16.30: Conclusion and statements of ISPOR SCP

  6. The Worldwide Role of Generic Pharmaceuticals Dr Jonathan D. Quick, Director Essential Drugs and Other Medicines - EDM Health Technology and Pharmaceuticals Cluster World Health Organization June, 1999

  7. Effective Drug Regulation: what can countries do? Essential Drugs and Other Medicines Department Health Technology and Pharmaceuticals Cluster World Health Organization March 1999

  8. Pharmacoeconomics: What is it and where is it going?JS McCombs, Am J Hip., 11: 1125, 1998 Gained years/cost dolar

  9. FACTORS EFFECTS RIGHT DESICION M X C P = B P= Performans M= Motivation C= Competence B= Barriers

  10. DESICION MAKERS Old system New system Patient needs Patient needs Administrators’ desicion Physicians’ desicion Administrators’ applicatin Physicians’ application

More Related